NRG Oncology

NCT07554573

Phase 3Not yet recruiting20275,270 people28 Apr 2026clinicaltrials.gov

NCT07452458

Phase 3Recruiting2026398 people5 Mar 2026clinicaltrials.gov

NCT07441681

Phase 3Recruiting2026454 people2 Mar 2026clinicaltrials.gov

NCT07097142

Phase 3Recruiting2025486 people31 Jul 2025clinicaltrials.gov

NCT06958328

Phase 3Recruiting2025356 people6 May 2025clinicaltrials.gov

NCT06745024

Phase 3Active, not recruiting2025280 people20 Dec 2024clinicaltrials.gov

NCT06235697

CollaboratorPhase 3Recruiting2024710 people1 Feb 2024clinicaltrials.gov

NCT06205485

CollaboratorPhase 3Recruiting2024250 people16 Jan 2024clinicaltrials.gov

NCT05946213

Phase 3Recruiting20231,209 people14 Jul 2023clinicaltrials.gov

NCT05624996

Phase 3Recruiting2023474 people22 Nov 2022clinicaltrials.gov

NCT05095376

Phase 3Active, not recruiting2022265 people27 Oct 2021clinicaltrials.gov

NCT05076942

CollaboratorPhase 2Recruiting2021157 people13 Oct 2021clinicaltrials.gov

NCT05050162

Phase 2/3Suspended20221,714 people20 Sept 2021clinicaltrials.gov

NCT05050084

Phase 3Active, not recruiting20212,050 people20 Sept 2021clinicaltrials.gov

NCT04852887

Phase 3Recruiting20211,670 people21 Apr 2021clinicaltrials.gov

NCT04804644

Phase 3Active, not recruiting2021152 people18 Mar 2021clinicaltrials.gov

NCT04588246

Phase 3Terminated202119 people19 Oct 2020clinicaltrials.gov

NCT04541355

CollaboratorPhase 2Completed202016 people9 Sept 2020clinicaltrials.gov

NCT04513717

Phase 3Active, not recruiting20212,753 people14 Aug 2020clinicaltrials.gov

NCT04458909

CollaboratorPhase 3Terminated202015 people7 Jul 2020clinicaltrials.gov